Advertisement

Search Results for "Meda Us Pharmaceutical 2011 Financial Results"

03:36 EDT 19th May 2013 | BioPortfolio

Original Source: The Top 100 Pharmaceutical Companies

The Top 100 Pharmaceutical Companies, determined by total sales in 2011 - see below for 2010 and  2009: They are listed in descending order with the sales in 2011 in $ million; Pfizer  ~  57,747 Sanofi  ~  46,454 Novartis&n...

Matching Channels

College Hill - international business communications consultancy

College Hill is a growing international business communications consultancy with offices in Europe, China, India, South Africa and the United States. College Hill's wide range of complementar...

The Asymptomatic Patient With Abnormal Laboratory Test Results

The Top 100 Pharmaceutical Companies

The Top 100 Pharmaceutical Companies, determined by total sales in 2011 - see below for 2010 and  2009: They are listed in descending order with the sales in 2011 in $ million; Pfizer ...

Top 50 Biopharma Products 2011

Ronald A. Rader, president of the Biotechnology Information Institute provided Contract Pharma a list of the Top 57 Biopharma Products by 2011 revenues (in millions). Mr. Rader subscribes to the sam...

Cholesteryl Ester Transfer Protein (CETP)

The Cholesteryl Ester Transfer Protein (CETP) facilitates the transfer of cholesterol from HDL to other lipoproteins including LDL, in exchange for triglycerides. The CETP mediated transfer of chole...

Matching News

Meda's Zyclara approved in the EU

Sweden-based Meda (OMX: MEDA A) yesterday announced that the European Commission has granted marketing authorization for Zyclara (imiquimod 3.75% cream), a patented product for the treatment of actini...

Meda pays $95m for Jazz women's products

Jazz Pharmaceuticals has completed the sales of its women's health business to Meda of Sweden for $95 million in cash. The six products being transferred generated sales of $30.4 million in 2011, and...

MEDA AB (publ) NOTICE OF ANNUAL GENERAL MEETING 2013

Regulatory News: Notice is hereby given that the Annual General Meeting (AGM) of Meda AB, corporate ID 556427-2812, will be held at 5.00 PM on Tuesday, May 7, 2013, at Meda's headquarters at Piper...

CEO Anders Lönner Increases Shareholding in Meda

Regulatory Mews: CEO Anders Lönner has increased its shareholding in Meda (STO:MEDAA) by the acquisition of 80 000 shares. MEDA AB (publ) is a leading in...

Jazz Pharma sells women's health business to Meda for $95 million

US drugmaker Jazz Pharmaceuticals (Nasdaq: JAZZ) today announced a definitive agreement to sell its women's health business, which includes six products, to Sweden-based Meda (OMX: MEDA) for $95 milli...

News briefs: Meda's Edluar; DebiopharmAscepion; MallinckrodtHorizon

Swedish drugmaker Meda AB (OMX: MEDA A) says that is Edluar, an oral sublingual formulation of zolpidem, has received registration approval in Europe via the decentralized procedure with Sweden acting...

Jazz Pharma completes women's health unit sale

Irish drugmaker Jazz Pharmaceuticals PLC said Monday that it completed the sale of its women's health business to Swedish pharmaceutical company Meda AB.Jazz agreed to sell the business to Meda in Se...

Meda AB (publ) AGM bulletin

Regulatory News: At the annual general meeting (AGM) on May 7, 2013, of Meda AB (publ)(STO:MEDAA), corporate ID 556427-2812, Box 906, SE-170 09 Solna, Sweden, declared a dividend of 2,25 SEK per s...

Matching PubMed Articles

Neurotoxicity of "ecstasy" and its metabolites in human dopaminergic differentiated SH-SY5Y cells.

"Ecstasy" (3,4-methylenedioxymethamphetamine or MDMA) is a widely abused recreational drug, reported to produce neurotoxic effects, both in laboratory animals and in humans. MDMA metabolites can be ma...

Pro-oxidant effects of Ecstasy and its metabolites in mouse brain synaptosomes.

Background and purpose: 3,4-Methylenedioxymethamphetamine (MDMA or "ecstasy") is a worldwide major drug of abuse known to elicit neurotoxic effects. The mechanisms underlying the neurotoxic effects of...

Responding to the financial abuse of people with dementia: a qualitative study of safeguarding experiences in England.

ABSTRACTBackground: The risks of financial exploitation and abuse of people with dementia remain under-researched. Little is known of the views of those responsible for local adult safeguarding system...

Financial Distress and Depressive Symptoms among African American Women: Identifying Financial Priorities and Needs and why it Matters for Mental Health.

Prior research found that financial hardship or distress is one of the most important underlying factors for depression/depressive symptoms, yet factors that contribute to financial distress remain un...

Attitudes towards credit and finances among college students in China and the United States.

Although there is growing concern about the issue of credit card debt among college students in China, little research has examined attitudes to money and debt among that group. The present study comp...

Search Whole site using Google

Loading
Search BioPortfolio:
Advertisement
Advertisement
Advertisement Advertisement